Evidence map›Paper›PMID 36642517›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Paralytic Ileus during Treatment of Pulmonary and Renal Tuberculosis in a Non-Human Immunodeficiency Virus Patient: An Unusual Presentation of Tuberculosis-immune Reconstitution Inflammatory Syndrome.

Toyohiro Hashiba, Mai Sugahara, Yui Ota, Ken Kaseda, Yusuke Kashiwagi, Motonobu Nakamura, Takayuki Shinohara, Mahoko Ikeda, Shu Okugawa, Kazuma Sugimoto and 6 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Toyohiro HashibaDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Mai SugaharaDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Yui OtaDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Ken KasedaDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Yusuke KashiwagiDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Motonobu NakamuraDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
Takayuki ShinoharaDepartment of Infectious Diseases, the University of Tokyo Hospital, Japan.
Mahoko IkedaDepartment of Infectious Diseases, the University of Tokyo Hospital, Japan.
Shu OkugawaDepartment of Infectious Diseases, the University of Tokyo Hospital, Japan.
Kazuma SugimotoDepartment of Urology, the University of Tokyo Hospital, Japan.
Kenichi SasakiDepartment of Urology, the University of Tokyo Hospital, Japan.
Yoshifumi HamasakiDepartment of Hemodialysis & Apheresis, the University of Tokyo Hospital, Japan.
Daisuke YamadaDepartment of Urology, the University of Tokyo Hospital, Japan.
Haruki KumeDepartment of Urology, the University of Tokyo Hospital, Japan.
Kyoji MoriyaDepartment of Infectious Diseases, the University of Tokyo Hospital, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, the University of Tokyo Hospital, Japan.
University of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paralytic ileus as tuberculosis-immune reconstitution inflammatory syndrome (TB-IRIS) is extremely rare. We herein report a 44-year-old man with pulmonary and renal tuberculosis who developed paralytic ileus 14 days after starting antituberculosis therapy (ATT) despite an initial favorable response to ATT. Paralytic ileus was successfully managed with conservative care. He initially required hemodialysis because of obstructive uropathy due to renal tuberculosis, but he was able to withdraw from dialysis after placement of ureteral stents. TB-IRIS can affect organs other than the original sites of tuberculosis, and the combined use of steroids may be effective for its prevention and treatment.

Indexed as

Antitubercular AgentsImmune Reconstitution Inflammatory SyndromeIntestinal Pseudo-ObstructionTuberculosis, PulmonaryTuberculosis, RenalAdultHumansMaleTomography, X-Ray ComputedAntitubercular Agentsabdominal symptomshemodialysisparalytic ileussteroidstuberculosistuberculosis-immune reconstitution inflammatory syndrome

Identifiers

PMID36642517
PMCPMC10518560
OpenAlexW4316171276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.